Clinical Trial

Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate (MF)

Study acronym: ENHANCE II
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The primary objective of the study is to evaluate the safety and effectiveness of OCEAN as an adjunct aid in wound healing after nasal/sinus surgery and to demonstrate that OCEAN is non-inferior compared to a steroid-eluting sinus stent.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-10.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-06-22
Trial Details
NCT Number NCT07286201
Lead Sponsor Polyganics BV
Collaborators: NAMSA
Conditions Chronic Rhinosinusitis (CRS), Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Enrollment 110 participants
Start Date 2026-03-19
Primary Completion 2027-03 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-25